Neuroimaging team led by Tammie Benzinger @WUSTL@MIRNeuro in NIL, leading Knight Alzheimer @WUADRC Research Imaging (KARI), DIAN & DIAN-TU Imaging Cores.
Congratulations Dr. Elizabeth Kras for an outstanding presentation at @SNM_MI today. Dr. Kras is the Brain Imaging Council Mentored Grant recipient . @WashUMedMIR
ALT ARIA (Amyloid-Related Imaging Abnormalities) refers to brain changes seen on MRI scans in Alzheimer's patients receiving anti-amyloid antibody therapies, such as Leqembi, that manifest as temporary swelling (ARIA-E) or microbleeds (ARIA-H). It requires monitoring due to the risk of severe symptoms such as confusion, headache, or vision issues, and may necessitate pausing treatment.
"The impact Dr. Benzinger has had on the lives of Alzheimer's patients is tremendous. I cannot think of anyone more deserving of this honor than her." - MIR Director Pamela Woodard, MD, who served as the inaugural Hugh Monroe Wilson Professor of Radiology.
Benzinger delivers her first lecture formally as Wilson Professor of Radiology on her groundbreaking neuroimaging work in "Advancing Frontiers in Brain Imaging: Translating Alzheimer's Research into Clinical Medicine.”
We're delighted to install Tammie Benzinger, MD, PhD, as the Hugh Monroe Wilson Professor of Radiology. A renowned physician-scientist, she has made significant strides in advancing neuroimaging and leading Alzheimer's research.
My first in-person attendance at @alzassociation conference and AIC pre-conference @NeuroimagingPIA to showcase Raji brain health lab research at #AAIC2024 meeting in Philly, connect with colleagues and learn more about Alzheimer’s disease research!
Great work by Matt Brier finding a lower rate of amyloid pathology in older patients with multiple sclerosis. Also, interesting case of a cognitively unimpaired MS patient on immunosuppressive therapy with normal %p-tau217, very high amyloid PET burden (centiloid 109), and negative tau PET. This is telling us something important about the biology of AD.
@WashUNeurology#ENDALZ@MatthewBrier@BenzingerNeuro1@BrianGordon81@cyrusrajionlinelibrary.wiley.com/doi/…
Yesterday’s Knight ADRC Tuesday Noon Seminar was fascinating! Some key points (as far as I gathered), if it’s okay I mention are: domain-specific and general cognitive composites, complex cognitive data, and AD biomarkers in the sphere of normal aging and neurodegen. disease.